14-day Premium Trial Subscription Sign Up For FreeGet Free

Eyegate Pharmaceuticals Stock Forecast NASDAQ:EYEG

$1.95 (0%)

Volume: 0

Closed: Dec 03, 2021

Hollow Logo Score: 0.000

Eyegate Pharmaceuticals Stock Forecast

$1.95 (0%)

Volume: 0

Closed: Dec 03, 2021

Score Hollow Logo 0.000
Which way will EYEG go? Request
Stop-loss: $1.83 (-6.00%)
Key Stats
Beta 0.76
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
RSImin/max Values: [ 25 - 75 ] RSI14 is 50 and the stock is currently not being overbought or oversold

Eyegate Pharmaceuticals stock price down 0% on Friday
(Updated on Dec 03, 2021)

Buy or Hold candidate since 2021-11-02 Loss -7.58%

No changes to the price of Eyegate Pharmaceuticals stock on the last trading day (Friday, 3rd Dec 2021). During the day the stock fluctuated 0% from a day low at $1.95 to a day high of $1.95. The price has been going up and down for this period, and there has been a 0% change for the last 2 weeks.

The stock lies in the middle of a very wide and weak rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 7.92% during the next 3 months and, with a 90% probability hold a price between $1.90 and $2.56 at the end of this 3-month period.

Signals & Forecast

There are mixed signals in the stock today. The Eyegate Pharmaceuticals stock holds sell signals from both short and long-term moving averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $1.95 and $1.96. A break-up above any of these levels will issue buy signals. Volume fell on the last day without any changes to the price. This does not cause any direct divergence but may be an early warning and a possible "turning point". The very low volume increases the risk and reduces the other technical signals issued. A buy signal was issued from a pivot bottom point on Friday, November 05, 2021, and so far it has fallen 0%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss

Eyegate Pharmaceuticals finds support from accumulated volume at $1.90 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

In general the stock tends to have very controlled movements and therefore the general risk is considered very low. However, be aware of low or falling volume and make sure to keep an eye on the stock During the last day, the stock moved $0 between high and low, or 0%. For the last week the stock has had a daily average volatility of 0%

Our recommended stop-loss: $1.83 (-6.00%) (This stock has low daily movements and this gives low risk. There is a buy signal from a pivot bottom found 19 days ago.)

Is Eyegate Pharmaceuticals stock A Buy?

Eyegate Pharmaceuticals holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

Current score: 0.000

Zero in score indicates that our system is expecting high volatility and risk for the following trading day. Given the latest developments, we cannot determine the next direction as it may go both ways.

Predicted Opening Price for Eyegate Pharmaceuticals of Monday, December 6, 2021

The predicted opening price is based on yesterday's movements between high, low, and the closing price.

Fair opening price December 6, 2021 Current price
$1.95 $1.95 (Undervalued)
Hold/Accumulate Unchanged

Remember To Visit Our YouTube Channel

Analyst Ratings

On Sep 09, 2021 "HC Wainwright" gave "$11.00" rating for EYEG. The price target was changed from $1.58 to 0.6%.

Volatility and Risk
Daily Average Volatility: 0 %
Overall Risk: Very High High Medium Low Very Low
0 %
Daily Average Volatility
Overall Risk

Very High
Very Low

Support & Resistance

Resistance: $2.00
Price: $1.95
Support: $1.90

EYEG Insider Trading Show all Trades



Last 100 transactions
Buy: 4 179 367 | Sell: 3 442 080 (Shares)
Date Action Amount Person Type
Nov 02, 2021 Sell 83 Romano Sarah Common Stock
Nov 02, 2021 Sell 62 Mann Brenda Common Stock
Nov 02, 2021 Sell 250 From Stephen Common Stock
Oct 21, 2021 Buy 50 000 Daniels Eric Joseph Stock Option (right to buy)
Oct 04, 2021 Sell 249 From Stephen Common Stock
Show all Insider Trades


Last 100 transactions
Buy: 4 179 367 | Sell: 3 442 080 (Shares)

Fibonacci Support & Resistance Levels

Level Price Change
Resistance 1.95 .
1.95 .
1.95 .
Current price: 1.95
Support 1.95 .
1.95 .
1.95 .

Accumulated Volume Support & Resistance Levels

Level Price Chg %
Resistance 2.25 15.38 %
2.10 7.69 %
2.00 2.56 %
Current price 1.95
Support 1.90 -2.56%
1.83 -6.15%
1.82 -6.67%

Click to get the best stock tips daily for free!

About Eyegate Pharmaceuticals

Eyegate Pharmaceuticals Eyegate Pharmaceuticals, Inc., a clinical-stage specialty pharmaceutical company, focuses on developing and commercializing therapeutics and drug delivery systems for treating eye diseases. The company is developing EGP-437 that has completed Phase III clinical trials in anterior uveitis for the treatment of various inflammatory conditions of the eye, including uveitis, a debilitating form of intraocular inflammation of the anterior portion of th... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 100 000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE